⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Goldman Sachs CEO Lloyd Blankfein Has Cancer

Published 09/22/2015, 08:20 AM
Updated 09/22/2015, 08:45 AM
© Reuters. Goldman Sachs Chairman and CEO, Lloyd Blankfein, waits to speak at the 10,000 Women-State Department Entrepreneurship Program in Washington, March 9, 2015.
GS
-

By Cristina Silva -

© Reuters. Goldman Sachs Chairman and CEO, Lloyd Blankfein, waits to speak at the 10,000 Women-State Department Entrepreneurship Program in Washington, March 9, 2015.

The chief executive officer of Goldman Sachs (NYSE:GS) announced he has a "highly curable" cancer Tuesday. CEO Lloyd Blankfein said he has lymphoma in a message to clients and shareholders. He said he will receive chemotherapy treatment over the next few months in New York and will continue to lead Goldman Sachs.

"I will be able to work substantially as normal, leading the firm," he wrote. "I will, however, reduce some of my previously planned travel during the treatment period. I have discussed this approach with our Board of Directors and they are supportive."

Goldman Sachs was up 1.8 percent to $184.09 in morning trading Monday. Below is Blankfein's full message to clients and shareholders:

"Late this summer after several weeks of not feeling well, I underwent a series of tests, which culminated in a biopsy last week. After the biopsy, I was told by my doctors that I have lymphoma. Fortunately, my form of lymphoma is highly curable, and my doctors' and my own expectation is that I will be cured.

"My treatment plan will include chemotherapy over the next several months in New York. My doctors have advised me that during the treatment, I will be able to work substantially as normal, leading the firm. I will, however, reduce some of my previously planned travel during the treatment period. I have discussed this approach with our Board of Directors and they are supportive.

There are many people who are dealing with cancer every day. I draw on their experiences as I begin my own. I have a lot of energy, and I'm anxious to begin the treatment. I appreciate your support and good wishes."

.@GoldmanSachs CEO Lloyd Blankfein announces that he has lymphoma http://t.co/99K2tu6fSy pic.twitter.com/M7baKhLYB5

— BuzzFeed News (@BuzzFeedNews) September 22, 2015

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.